| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $637.8M | +18.8% |
| Cost of Revenue | $210.7M | +15.7% |
| Gross Profit | $427.1M | +20.3% |
| R&D Expense | $62.8M | +17.1% |
| SG&A Expense | $102.9M | +21.3% |
| Operating Income | $88.9M | +15.1% |
| Pre-tax Income | $99.5M | +16.3% |
| Income Tax | $22.4M | +13.6% |
| Net Income | $77.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $241.0M | +10.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $52.0M | +11.1% |
| Current Assets | $381.9M | -4.9% |
| Total Assets | $1.03B | +25.2% |
| Current Liabilities | $146.7M | +12.3% |
| Total Liabilities | $176.5M | +12.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $157.4M | +19.0% |
| Capital Expenditures | $20.0M | +1.4% |
| Investing Cash Flow | -$110.5M | -19.2% |
| Financing Cash Flow | -$23.0M | -244.2% |
| Free Cash Flow | $137.4M | +22.1% |
| +17.1% |
| EPS (Basic) | $2.07 | +15.0% |
| EPS (Diluted) | $2.04 | +15.9% |
| Stockholders' Equity |
| $854.7M |
| +28.0% |